Building a Stronger Evidence Base on Malaria Elimination

-
Investigator: Richard G. Feachem, DSc, PhD
Sponsor: Bill & Melinda Gates Foundation

Location(s): Botswana; Namibia; South Africa; Swaziland; Mali; China; North Korea; South Korea; Bhutan; Nepal; Sri Lanka; Cambodia; Indonesia; Viet Nam; Malaysia; Thailand; Philippines; Solomon Islands; Vanuatu

Description

The Global Health Group bridges the gap between evidence, policy and implementation to stimulate practical international and local action to solve critical health challenges. Our small but highly leveraged team of global health experts conducts targeted research and advocacy on behalf of our signature initiatives, expanding global understanding and engaging an ever-growing network of partners to take forward new approaches.

Through our work, policymakers, funders and country leaders gain access to new and relevant data, recommendations and tools—and make informed decisions about the next important steps in strategy, funding and implementation.

The Evidence to Policy Initiative (E2Pi) works to narrow the gap between evidence and policy in global health, creating the tools and information policymakers need in order to make informed decisions.

The Malaria Elimination Initiative provides intellectual and practical support to countries around the world that are pursuing a goal of malaria elimination. MEI advocates for and supports spatially progressive elimination — working inwards from the current geographic margins of the disease — as a complementary strategy to scaled-up malaria control in highly endemic countries, and research and development of new tools to eventually eradicate the disease.

The Private Sector Healthcare Initiative advances the understanding of private sector healthcare provision in developing countries. Given the primacy of private healthcare services in developing countries, the private sector is a crucial focus area for overall health systems strengthening. Goals are to improve the evidence base on the private health sector in developing countries, advance the global understanding of the significance of private sector healthcare provision in low- and middle-income countries, and ultimately, enable governments to more effectively interact with the private sector in order to achieve public health goals.